Volume 17 Supplement 1
T1 mapping by CMR in patients with arrhythmic cardiomyopathy
© Zhao et al; licensee BioMed Central Ltd. 2015
Published: 3 February 2015
Traditionally, late gadolinium enhancement (LGE) helps effectively detect focal fibrosis in cardiomyopathy. If patients have diffuse fibrosis, LGE could not provide enough objective evaluation of the severity of the disease. Arrhythmic cardiomyopathy (ACM) is a clinical entity which corresponds to all myocardial changes induced by chronic tachycardia. For ACM patients, myocardial fibrosis evaluation is important for treatment and prognosis. Accordingly, we aimed at exploring associations between myocardial T1 changes as a surrogate for left ventricular (LV) interstitial fibrosis in ACM.
Twenty-one patients with ACM underwent cardiac magnetic resonance (CMR) before catheter ablation. 19 healthy volunteers served as control group. CMR imaging was performed at 3.0T (Siemens MAGNETOM Verio) including cine, pre- and post-contrast T1 mapping, and LGE imaging. T1-maps were obtained in the same short-axis planes of LGE imaging before and 15minutes after the administration of gadolinium by using a modified Look-Locker (MOLLI) sequence. T1 times in 3 short axis slices (basal, mid-ventricular and apical) were evaluated.
Arrhythmic cardiomyopathy patients' myocardium show increased pre-contrast T1 times, decreased post-contrast T1 times and increased reductions in myocardial T1 times compared with healthy person. Abnormal myocardial T1 times, a surrogate of diffuse interstitial fibrosis, are found in arrhythmic cardiomyopathy.
Supported by the China National Natural Science Fund Grant (81101173).
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.